Canadian premiers blame Ottawa for delayed COVID-19 shots

Premiers say federal COVID-19 vaccine procurement delays have left them no choice but to stretch out the time between doses, as pharmacies in some parts of Ontario were preparing to start giving shots next week.

Alberta Premier Jason Kenney said Thursday that he had asked chief medical officer Dr. Deena Hinshaw some time ago to take a serious look into allowing a four-month gap between shots after seeing “tremendous” results in the United Kingdom and Israel.

He said an outbreak driven by a new, more transmissible COVID-19 variant started at a seniors’ home in Edmonton on Monday just as residents were supposed to be receiving their vaccines.

“They should have been vaccinated weeks ago, like they were in similar settings in the United States, Israel, the U.K. and many, many other countries,” he said following a virtual premiers’ meeting.

“This is extremely frustrating and I think we have no choice but to expand the interval to get more people covered.”

Story continues below advertisement

READ MORE: Alberta to start extending time between COVID-19 vaccine doses as 1st variant outbreak declared 

British Columbia announced Monday that it would be allowing up to four months between doses. Several other provinces followed suit after a national panel of vaccine experts recommended Wednesday that such an extension would be appropriate if supplies are limited.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

Labels of the Pfizer-BioNTech and Moderna vaccines call for a three or four-week gap between doses.

Research has shown one dose is 70 to 80 per cent effective for up to two months, but it’s unclear how long protection lasts beyond that.

Saskatchewan Premier Scott Moe said Thursday his province is moving to the four-month interval because the federal government has done a “disappointing job at best” in quickly getting vaccines to provinces.

Manitoba Premier Brian Pallister added: “Let’s face it: this strategy has become necessary as a consequence of an absence of vaccines.”

READ MORE: Premiers call on feds to boost health funds, warn of ‘post-pandemic pileup’ 

A Health Canada official said Thursday that a decision on Johnson and Johnson’s COVID-19 vaccine could come “within days.” It would be the fourth to be approved, following ones from Pfizer-BioNTech, Moderna and Oxford-AstraZeneca.

Story continues below advertisement

Maj.-Gen. Dany Fortin, who is leading Ottawa’s vaccine rollout, told a media briefing that nearly three million doses have been distributed to the provinces and territories so far.

“In April, we’re anticipating a steep increase in vaccine availability,” he said. That includes 23 million doses of the Pfizer-BioNTech and Moderna vaccines between April and June and at least 1.5 million of the Oxford-AstraZeneca vaccine by mid-May.

Ontario Health Minister Christine Elliott said many of the Oxford-AstraZeneca doses the province receives will go to pharmacies for a pilot program beginning next week. The Ontario Pharmacists Association said about 380 pharmacies in Toronto, Kingston and Windsor-Essex will be doling out shots initially.

A similar program in Alberta began with pharmacies in Edmonton, Red Deer and Calgary this week.

Meanwhile, Nova Scotia is easing public-health restrictions in and around Halifax. Health officials in the Atlantic province said rules that came into effect last week limiting restaurant hours, prohibiting sports events and discouraging non-essential travel will end Friday morning in the capital region.

Nova Scotia reported three new cases Thursday and 29 active ones.

Ontario, meanwhile, recorded 994 new infections, almost four per cent higher than the previous report, but the third straight day below 1,000. It also linked 10 more deaths to the virus.

Story continues below advertisement

Quebec said it had 707 new cases, along with 20 additional deaths. It is easing restrictions in Quebec City and four other regions starting Monday, but keeping them in place in the Montreal area due to concern over variants.

© 2021 The Canadian Press

Latest articles

Related articles